Bisphosphonates and osteonecrosis of the jaw: Moving from the bedside to the bench

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Osteonecrosis of the jaw (ONJ) has received significant attention as a potential side effect of bisphosphonate treatment. The limited understanding of the underlying pathophysiology of the condition emphasizes the need to transition ONJ research from the bedside to the bench, supplementing ongoing clinical research with animal/basic science studies. The goal of this review is to briefly highlight the most commonly proposed mechanisms for ONJ and then summarize our laboratory's recent efforts to begin transitioning ONJ research to an animal model. Remodeling suppression, disrupted angiogenesis and infection have all been proposed to connect bisphosphonates to ONJ, although most supportive data for each of these are either indirect or nonexistent. Our laboratory has begun studying the dog as a potential model of ONJ. We have shown regions of necrotic bone matrix within the mandible of dogs treated with oral or intravenous bisphosphonate. We hypothesize these regions are the result of remodeling suppression, and if combined with additional factors such as dental intervention or infection, would result in manifestation of exposed oral lesions, the clinical definition of ONJ. Although these findings suggest the dog may be a viable animal model to study ONJ, many questions remain unanswered. No matter what animal model is found to mimic the clinical presentation of ONJ, once established it will allow significant progress toward understanding the specific role of bisphosphonates in the pathophysiology of ONJ and if/how the entity of ONJ can best be treated and prevented.

Original languageEnglish
Pages (from-to)289-294
Number of pages6
JournalCells Tissues Organs
Volume189
Issue number1-4
DOIs
StatePublished - Dec 2008

Fingerprint

Bisphosphonate-Associated Osteonecrosis of the Jaw
Osteonecrosis
Jaw
Diphosphonates
Animal Models
Dogs
Oral Manifestations
Bone Matrix
Infection
Mandible
Research
Tooth

Keywords

  • Animal models
  • Bisphosphonate
  • Mandible
  • Osteonecrosis of the jaw
  • Remodeling suppression
  • Review

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Bisphosphonates and osteonecrosis of the jaw : Moving from the bedside to the bench. / Allen, Matthew.

In: Cells Tissues Organs, Vol. 189, No. 1-4, 12.2008, p. 289-294.

Research output: Contribution to journalArticle

@article{879771245e9a48fcb1285fb93508b005,
title = "Bisphosphonates and osteonecrosis of the jaw: Moving from the bedside to the bench",
abstract = "Osteonecrosis of the jaw (ONJ) has received significant attention as a potential side effect of bisphosphonate treatment. The limited understanding of the underlying pathophysiology of the condition emphasizes the need to transition ONJ research from the bedside to the bench, supplementing ongoing clinical research with animal/basic science studies. The goal of this review is to briefly highlight the most commonly proposed mechanisms for ONJ and then summarize our laboratory's recent efforts to begin transitioning ONJ research to an animal model. Remodeling suppression, disrupted angiogenesis and infection have all been proposed to connect bisphosphonates to ONJ, although most supportive data for each of these are either indirect or nonexistent. Our laboratory has begun studying the dog as a potential model of ONJ. We have shown regions of necrotic bone matrix within the mandible of dogs treated with oral or intravenous bisphosphonate. We hypothesize these regions are the result of remodeling suppression, and if combined with additional factors such as dental intervention or infection, would result in manifestation of exposed oral lesions, the clinical definition of ONJ. Although these findings suggest the dog may be a viable animal model to study ONJ, many questions remain unanswered. No matter what animal model is found to mimic the clinical presentation of ONJ, once established it will allow significant progress toward understanding the specific role of bisphosphonates in the pathophysiology of ONJ and if/how the entity of ONJ can best be treated and prevented.",
keywords = "Animal models, Bisphosphonate, Mandible, Osteonecrosis of the jaw, Remodeling suppression, Review",
author = "Matthew Allen",
year = "2008",
month = "12",
doi = "10.1159/000151371",
language = "English",
volume = "189",
pages = "289--294",
journal = "Cells Tissues Organs",
issn = "1422-6405",
publisher = "S. Karger AG",
number = "1-4",

}

TY - JOUR

T1 - Bisphosphonates and osteonecrosis of the jaw

T2 - Moving from the bedside to the bench

AU - Allen, Matthew

PY - 2008/12

Y1 - 2008/12

N2 - Osteonecrosis of the jaw (ONJ) has received significant attention as a potential side effect of bisphosphonate treatment. The limited understanding of the underlying pathophysiology of the condition emphasizes the need to transition ONJ research from the bedside to the bench, supplementing ongoing clinical research with animal/basic science studies. The goal of this review is to briefly highlight the most commonly proposed mechanisms for ONJ and then summarize our laboratory's recent efforts to begin transitioning ONJ research to an animal model. Remodeling suppression, disrupted angiogenesis and infection have all been proposed to connect bisphosphonates to ONJ, although most supportive data for each of these are either indirect or nonexistent. Our laboratory has begun studying the dog as a potential model of ONJ. We have shown regions of necrotic bone matrix within the mandible of dogs treated with oral or intravenous bisphosphonate. We hypothesize these regions are the result of remodeling suppression, and if combined with additional factors such as dental intervention or infection, would result in manifestation of exposed oral lesions, the clinical definition of ONJ. Although these findings suggest the dog may be a viable animal model to study ONJ, many questions remain unanswered. No matter what animal model is found to mimic the clinical presentation of ONJ, once established it will allow significant progress toward understanding the specific role of bisphosphonates in the pathophysiology of ONJ and if/how the entity of ONJ can best be treated and prevented.

AB - Osteonecrosis of the jaw (ONJ) has received significant attention as a potential side effect of bisphosphonate treatment. The limited understanding of the underlying pathophysiology of the condition emphasizes the need to transition ONJ research from the bedside to the bench, supplementing ongoing clinical research with animal/basic science studies. The goal of this review is to briefly highlight the most commonly proposed mechanisms for ONJ and then summarize our laboratory's recent efforts to begin transitioning ONJ research to an animal model. Remodeling suppression, disrupted angiogenesis and infection have all been proposed to connect bisphosphonates to ONJ, although most supportive data for each of these are either indirect or nonexistent. Our laboratory has begun studying the dog as a potential model of ONJ. We have shown regions of necrotic bone matrix within the mandible of dogs treated with oral or intravenous bisphosphonate. We hypothesize these regions are the result of remodeling suppression, and if combined with additional factors such as dental intervention or infection, would result in manifestation of exposed oral lesions, the clinical definition of ONJ. Although these findings suggest the dog may be a viable animal model to study ONJ, many questions remain unanswered. No matter what animal model is found to mimic the clinical presentation of ONJ, once established it will allow significant progress toward understanding the specific role of bisphosphonates in the pathophysiology of ONJ and if/how the entity of ONJ can best be treated and prevented.

KW - Animal models

KW - Bisphosphonate

KW - Mandible

KW - Osteonecrosis of the jaw

KW - Remodeling suppression

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=56749143817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749143817&partnerID=8YFLogxK

U2 - 10.1159/000151371

DO - 10.1159/000151371

M3 - Article

C2 - 18698128

AN - SCOPUS:56749143817

VL - 189

SP - 289

EP - 294

JO - Cells Tissues Organs

JF - Cells Tissues Organs

SN - 1422-6405

IS - 1-4

ER -